论文部分内容阅读
目的研究吸入性糖皮质激素联合储雾罐与吸入性糖皮质激素联合雾化器治疗5岁以下喘息性患儿的临床疗效。方法 130例5岁以下喘息性患儿,按照治疗方法的不同分为研究组和对照组,各65例。对照组患儿采用吸入性糖皮质激素联合雾化器进行治疗,研究组患儿采用吸入性糖皮质激素联合储雾罐进行治疗。对两组患儿一般情况进行观察,并分析两组患儿的治疗有效率。结果两组患儿的气促缓解时间、哮鸣音消失时间和平均住院时间相比较,差异具有统计学意义(P<0.05);治疗后,研究组的治疗总有效率明显高于对照组,差异具有统计学意义(P<0.05)。结论吸入性糖皮质激素联合储雾罐可以显著改善5岁以下喘息性患儿的临床疗效,提高患儿预后效果,值得临床推广应用。
Objective To study the clinical efficacy of inhaled glucocorticoid combined with aerosol cans and inhaled glucocorticoid combined with nebulizer in the treatment of asthmatic children under 5 years of age. Methods 130 cases of asthmatic children under 5 years of age were divided into study group and control group according to the different treatment methods, 65 cases in each group. Children in the control group were treated with inhaled glucocorticoids and nebulizer. The children in the study group were treated with inhaled corticosteroids combined with aerosol cans. The general situation of two groups of children were observed, and analysis of the treatment of children with two groups of efficient. Results Compared with the control group, the total effective rate of treatment group was significantly higher than that of the control group (P <0.05). The difference was statistically significant (P <0.05) The difference was statistically significant (P <0.05). Conclusion Inhaled glucocorticoid combined with aerosol cans can significantly improve the clinical efficacy of asthmatic children under 5 years of age and improve the prognosis of children, worthy of clinical application.